---
title: "JIUDIAN PHARMACEUTICAL released its performance for the first half of the year, with a net profit attributable to the parent company of 291 million yuan, an increase of 2.57%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254122887.md"
description: "According to the Zhitong Finance APP, JIUDIAN PHARMACEUTICAL released its semi-annual report for 2025, showing an operating income of 1.512 billion yuan, a year-on-year increase of 10.67%. The net profit attributable to shareholders of the listed company was 291 million yuan, a year-on-year increase of 2.57%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 283 million yuan, a year-on-year increase of 10.74%. The basic earnings per share were 0.59 yuan"
datetime: "2025-08-22T08:35:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254122887.md)
  - [en](https://longbridge.com/en/news/254122887.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254122887.md)
generator: "portal-rs"
---

# JIUDIAN PHARMACEUTICAL released its performance for the first half of the year, with a net profit attributable to the parent company of 291 million yuan, an increase of 2.57%

According to the Zhitong Finance APP, JIUDIAN PHARMACEUTICAL (300705.SZ) released its semi-annual report for 2025, showing an operating income of 1.512 billion yuan, a year-on-year increase of 10.67%. The net profit attributable to shareholders of the listed company was 291 million yuan, a year-on-year increase of 2.57%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 283 million yuan, a year-on-year increase of 10.74%. The basic earnings per share were 0.59 yuan

### Related Stocks

- [300705.CN](https://longbridge.com/en/quote/300705.CN.md)

## Related News & Research

- [Under-eye patches aren’t just skincare anymore. Now, they're a flex.](https://longbridge.com/en/news/296597484.md)
- [11:00 ETLumenStim se prepara para lanzar en Kickstarter su sistema de blanqueamiento dental de última generación](https://longbridge.com/en/news/296633006.md)
- [08:38 ETThe 2027 NAMM Show Announces Global Five-Day Celebration of Music, Product Innovation and Industry Leadership](https://longbridge.com/en/news/296229778.md)
- [14:18 ETVascarta Announces NIH Phase I clinical study of VAS-101 in sickle cell disease begins](https://longbridge.com/en/news/296388379.md)
- [3 Ways to Slay: CurlyMe 3-In-1 Half Wig Sparks a New Hair Revolution](https://longbridge.com/en/news/296447697.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**